These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19403852)

  • 1. The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine.
    Smith MA; Greene-Naples JL; Felder JN; Iordanou JC; Lyle MA; Walker KL
    J Pharmacol Exp Ther; 2009 Aug; 330(2):476-86. PubMed ID: 19403852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors.
    Smith MA; Greene-Naples JL; Lyle MA; Iordanou JC; Felder JN
    J Pharmacol Exp Ther; 2009 Aug; 330(2):468-75. PubMed ID: 19403853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.
    Smith MA; Gordon KA; Craig CK; Bryant PA; Ferguson ME; French AM; Gray JD; McClean JM; Tetirick JC
    Psychopharmacology (Berl); 2003 May; 167(3):265-73. PubMed ID: 12669175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mu/kappa agonist nalbuphine attenuates sensitization to the behavioral effects of cocaine.
    Smith MA; Cole KT; Iordanou JC; Kerns DC; Newsom PC; Peitz GW; Schmidt KT
    Pharmacol Biochem Behav; 2013 Mar; 104():40-6. PubMed ID: 23305678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
    Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice.
    Kuzmin AV; Gerrits MA; Zvartau EE; van Ree JM
    Eur Neuropsychopharmacol; 2000 Dec; 10(6):447-54. PubMed ID: 11115734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
    Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice.
    Lesscher HM; Hordijk M; Bondar NP; Alekseyenko OV; Burbach JP; van Ree JM; Gerrits MA
    Neuropsychopharmacology; 2005 Feb; 30(2):278-85. PubMed ID: 15257307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole.
    Heidbreder C; Goldberg SR; Shippenberg TS
    Eur J Pharmacol; 1993 Oct; 243(2):123-7. PubMed ID: 8276060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
    Dykstra LA; Schoenbaum GM; Yarbrough J; McNutt R; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):875-82. PubMed ID: 8246162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms.
    Rowlett JK; Spealman RD; Platt DM
    Psychopharmacology (Berl); 2000 Jun; 150(2):191-9. PubMed ID: 10907672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.